Company / Total Debt
Larimar Therapeutics, Inc. Total Debt History
FY2017-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$20.0M
FY2017
5-year range
$20.0M / $20.0M
FY2017-FY2017
Trend
-
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$20M in FY2017.
Total Debt over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.64 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | $20.0M | - |
| FY2016 | - | - |
| FY2015 | - | - |
| FY2014 | - | - |
As of FY2017 · SEC 10-K · Updated Jun 24, 2026